Active Since: 2011
Contributing to SDGs…
Accelerating the discovery and development of technologies for neglected tropical diseases, malaria, and tuberculosis by sharing intellectual property with the global health research community, catalyzing and fostering global health collaborations, and contributing to capacity-building in low- and middle-income countries.
WIPO Re:Search Resource Platform
Academia or research institute
African Institute of Biomedical Science and Technology (AiBST)
California Institute of Technology
Council on Health Research for Development
Drugs for Neglected Diseases initiative (DNDi)
Indian Council of Medical Research
Infectious Disease Research Institute (IDRI)
International Vaccine Institute
Kenya Medical Research Institute
Kumasi Centre for Collaborative Research in Tropical Medicine
Liverpool School of Tropical Medicine
Massachusetts Institute of Technology
Murdoch Childrens Research Institute
National University of Singapore
Nigerian Institute of Medical Research
Sabin Vaccine Institute
South African Medical Research Council
University of Bamako
University of British Columbia
University of Buea
University of Calgary
University of Dundee
University of Edinburgh
University of Florida
University of Ibadan
University of Kansas
University of Lagos
University of Mauritius
University of New South Wales
University of South Florida
University of Vermont
University of Washington
University of Yaound
Walter and Eliza Hall Institute of Medical Research
Walter Reed Army Institute of Research
Addis Ababa University
Ahmadu Bello University
Armauer Hansen Research Institute
Bandung Institute of Technology
Biomedical Center of the Central University of Ecuador
Case Western Reserve University
Center for Molecular Dynamics Nepal
Center for World Health Medicine
Centre for Plant Medicine Research
Congolese Foundation for Medical Research
Griffith Institute for Drug Discovery
Health Sciences Research Institute
Icahn School of Medicine at Mount Sinai
Institute of Molecular and Cellular Biology of Rosario
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B)
James Cook University
Medical Research Institute - Alexandria University
Public Health Research Institute
Seattle Children's Research Institute
Social Medicine Institute - Rio de Janeiro State University
Texas Children’s Hospital Center for Vaccine Development
George Washington University
Umaru Musa Yar’adua University
University Cheikh Anta Diop of Dakar
University of Bamenda
University of California, Berkeley
University of California, San Diego (UCSD)
University of California, San Francisco
University of Campinas
University of Dschang
University of Georgia
University of Ghana
University of Melbourne
University of Papua New Guinea - School of Medicine and Health Sciences
University of São Paulo
University of South Carolina
University of Texas - Southwestern Medical Center
University of Toronto
University of Zambia
Usmanu Danfodiyo University, Sokoto
Washington University in St. Louis
National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand
National Institute for Medical Research (NIMR)
National Institute of Immunology, India
Research Institute for Tropical Medicine
Theodor Bilharz Research Institute
Institut Pasteur Korea
Noguchi Memorial Institute for Medical Research
Drugs for Neglected Diseases initiative (DNDi)
Africa Fighting Malaria
Developing World Health
PATH Malaria Vaccine Initiative (MVI)
Biomedical Research Institute
Global Alliance for Livestock Veterinary Medicines (GALVmed)
Structural Genomics Consortium
Centre Pasteur du Cameroun
US National Institutes of Health (NIH)
US Patent and Trademark Office
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
Kenya Agricultural & Livestock Research Organisation
National Institute of Industrial Property
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention
Oswaldo Cruz Foundation
Eijkman Institute for Molecular Biology
International Hospital Federation (IHF)
Massachusetts General Hospital
Intergovernmental Organizations and Multilaterals
International Centre for Genetic Engineering and Biotechnology
Brazilian Biosciences National Laboratory
Institut Pasteur de Madagascar
Institut Pasteur de Tunis
Puerto Rico Science, Technology & Research Trust
Private foundation or development organization
Swiss Tropical and Public Health Institute (Swiss TPH)
Product development partnerships
Medicines for Malaria Venture (MMV)
Professional and trade associations
Association of University Managers
International Federation of Intellectual Property Attorneys
Licensing Executive Society International
Public Interest Intellectual Property Advisors
- Accelerating development of new vaccines, diagnostics, and drugs for malaria, tuberculosis (TB) and Neglected Tropical Diseases (NTDs).
- To create partnerships that connect private industry’s assets and resources with qualified academic and nonprofit researchers with novel product discovery or development ideas.
- Guiding principles to ensure products are available royalty free in least developed countries.
Partnership activities and how they address needs and challenges
WIPO Re:Search, a global consortium, was founded by the World Intellectual Property Organization (WIPO) in partnership with BIO Ventures for Global Health (BVGH) and several leading pharmaceutical companies in 2011. Consortium partners recognized the need to accelerate the development of new drugs, vaccines, and diagnostics for infectious diseases. Today, WIPO Re:Search continues to advance sharing of intellectual property toward R&D for neglected tropical diseases (NTDs), malaria, and tuberculosis.
As the Partnership Hub administrator of WIPO Re:Search, BIO Ventures for Global Health (BVGH) proactively examines scientists’ current neglected disease research and proposes novel collaboration opportunities with other Members. BVGH also fields requests from researchers, identifies Member organizations able to fulfill these requests, and helps forge mutually beneficial collaborations with clearly-defined roles, responsibilities, and expectations.
The World Intellectual Property Organization (WIPO) manages the WIPO Re:Search Resource Platform, a searchable, public database of available intellectual property assets and resources. WIPO Re:Search provides access to important IP resources to support its member organizations in research on vaccines, diagnostics, and drugs for NTDs, striving ultimately to improve the lives of those most in need. WIPO Re:Search Members include prestigious academic institutions and some of the world’s leading pharmaceutical companies..
Public-Private Partnership Activities
Eisai Co., Ltd. activities: Through WIPO Re:Search, Eisai has collaborated recently with University of Yaoundé I; Infectious Disease Research Institute; and University of Buea on solutions to neglected infectious diseases including human African trypanosomiasis, leishmaniasis, malaria, onchocerciasis, and tuberculosis.
GSK activities: Through WIPO Re:Search, GSK has collaborated recently with Washington University in St. Louis; University of California, San Francisco; and Fundação Oswaldo Cruz on solutions to neglected infectious diseases including Chagas disease and malaria.
Johnson & Johnson activities: Through WIPO Re:Search, Johnson & Johnson has collaborated recently with the Walter and Eliza Hall Institute of Medical Research; Washington University in St. Louis; National Institutes of Health; and University of Yaoundé I on solutions to neglected infectious diseases including human African trypanosomiasis, leishmaniasis, malaria, and tuberculosis.
Merck KGaA, Darmstadt, Germany activities: Through WIPO Re:Search, Merck KGaA has collaborated recently with University of California, San Diego; University of Yaoundé I; and University of Buea on solutions to neglected infectious diseases including Buruli ulcer, Chagas disease, human African trypanosomiasis, leishmaniasis, and onchocerciasis. Merck KGaA is known as EMD in the US and Canada.
MSD activities: Through WIPO Re:Search, MSD has collaborated recently with Seattle Children’s Research Institute/Seattle Structural Genomics Center for Infectious Disease; The George Washington University; and Walter and Eliza Hall Institute of Medical Research on solutions to neglected infectious diseases including malaria, schistosomiasis, and tuberculosis. MSD is a trademark of Merck & Co., Inc., Kenilworth, NJ, USA.
Novartis Pharma AG activities: Through WIPO Re:Search, Novartis has collaborated recently with Nigerian Institute of Medical Research; Brazilian Biosciences National Laboratory; and Public Health Research Institute on solutions to neglected infectious diseases including Chagas disease and malaria.
Pfizer Inc. activities: Through WIPO Re:Search, Pfizer has collaborated recently with Kenya Medical Research Institute; Washington University in St. Louis/The George Washington University; and Infectious Disease Research Institute on solutions to neglected infectious diseases including malaria and tuberculosis.
Takeda Pharmaceutical Company Limited activities: Through WIPO Re:Search, Takeda has collaborated recently with National Institutes of Health; Infectious Disease Research Institute; and Seattle Children’s Research Institute on solutions to neglected infectious diseases including Chagas disease, leishmaniasis, and malaria.
Elimination and eradication of malaria, tuberculosis, and neglected tropical diseases (NTDs) requires the coordinated efforts of international stakeholders from both the corporate and non-profit sectors. WIPO Re:Search is a unique and effective public-private partnership model for accelerating malaria, tuberculosis, and NTD R&D through the free sharing of IP assets.
One of the very best things that has happened to me and my institute in the recent past is being a member of WIPO Re:Search. WIPO Re:Search connects us with collaborators from developed countries. This is a feat that we have not been able to achieve for decades.
SDGs THE PARTNERSHIP CONTRIBUTES TO
SDG 3: Good Health and Wellbeing
- 3.2: Reduce Under-5 Mortality
- 3.3: Communicable Diseases & NTDs
SDG 9: Industry Innovation and Infrastructure
SDG 10: Reduced Inequalities
SDG 17: Partnerships for the Goals
RESULTS & MILESTONES
Membership has grown to include over 150 organisations representing over 40 countries. Since 2011, 154 research collaborations have been established between Members. 15 of these projects progressed to the next stage of product development. In 2019, there were 54 ongoing collaborations.
Malaria, tuberculosis, Chagas disease, schistosomiasis, and soil-transmitted helminthiases are the top five most common diseases subject to WIPO Re:Search collaborations established to date.
The WIPO Re:Search Fellowship Program is building an international community of researchers to catalyze R&D for neglected diseases. Key impacts include 20 fellowships totaling 100+ months of training and securing grant funding, including over US $750,000 for one fellow.
- WIPO Re:Search Resource Platform
- BVGH WIPO Re:Search
- Video - WIPO Re:Search - Sharing IP in the Fight Against Neglected Tropic Diseases
- News Release - Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search
- Report - Global Challenges In Focus
- Report - BVGH Partnership Hub Mid-Year Report 2019
- Report - BVGH Partnership Hub Annual Report 2018
Infectious and Parasitic Disease
Neglected Tropical Diseases (NTDs)
- Dracunculiasis (Guinea Worm)
- Buruli Ulcer
- Soil-Transmitted Helminthiasis
- Foodborne Trematodiases
- Dengue and Chikungunya
- Chagas Disease
- Onchocerciasis (River Blindness)
Vaccine preventable disease